Skip to main content

Branded

  • CVS Pharmacy locations now offering non-prescription naloxone in Idaho

    WOONSOCKET, R.I. - CVS Health announced Friday that the opioid overdose-reversal medication naloxone is now available without a prescription at CVS Pharmacy locations in Idaho. Under prescriptive authority allowed by the state, CVS Pharmacists will expand access to the medication.  

  • Study: Drug cost estimates trend higher than actual sales
    BEVERLY HILLS — Cost estimates put out before the launch of new drugs can often overestimate their impact on healthcare spending, according to a new study from research consultancy the Partnership for Health Analytics Research. 
     

  • Latest CDC study proves boomers benefit from flu shot

    ATLANTA - A new CDC study published Tuesday in the journal Clinical Infectious Diseases provides more evidence on the benefits of flu vaccination among older adults. The study looked at flu-associated hospitalizations among people 50 and older during the 2010-2011 flu season and found that people who had gotten a flu vaccine reduced their risk of flu-associated hospitalization by half.

  • Personalized solutions: Q&A with TopRx's Scott Franklin

    Scott Franklin, president of TopRx

  • Big-money meds lose patent protection in 2016

    Total spending on products whose patents expired between 2012 and 2015 declined by $14.2 billion last year, according to IMS Health’s Institute for Health Care informatics. And 2016 could bring about further cost reductions.

  • Companies fight to launch biosimilars amid expiries

    In April, the Food and Drug Administration granted approval to Pfizer’s Inflectra (infliximab) — a biosimilar of Janssen’s Remicade and possibly the second biosimilar to be launched in the United States. But like the first biosimilar, Zarxio (filgrastim-sndz), Inflectra is subject to a 180-day waiting period before launch, and is currently facing opposition from Janssen, which claims Remicade’s patent doesn’t expire until 2018.

  • All Walgreens pharmacies and Healthcare Clinics now offering bacterial meningitis vaccine daily

    DEERFIELD, Ill. - Walgreens is now offering vaccinations that provide protection against most strains of serogroup B meningococcal disease (bacterial meningitis) at all of its pharmacies, including Duane Reade pharmacies in New York and Healthcare Clinics nationwide.

  • Pfizer acquires Bamboo Therapeutics
    NEW YORK — In a move aimed at bolstering its position in the gene therapy field, Pfizer on Monday announced its acquisition of Bamboo Therapeutics. The Chapel Hill, N.C.-based company focuses on developing gene therapies for patients with rare diseases related to neuromuscular and central nervous system conditions. 
     
X
This ad will auto-close in 10 seconds